Results 1-6 of 6 for cervical speaker:Brian Cowen
- Leaders' Questions (12 Nov 2008)
Brian Cowen: ...tonight so there will be an opportunity for all Members to put their views on the record. Those who get the vaccine must also undergo screening. The vaccine is not 100% effective in preventing cervical cancer. It is important that we do not use emotional language but that we be specific. All people who receive the vaccination must be screened. Screening provides 95% protection against...
- Leaders' Questions (12 Nov 2008)
Brian Cowen: That is 300,000 people next year. We will keep this matter under review. It is the screening programme that identifies the pre-cancerous cells and ensures cervical cancer does not take hold. That is the issue. I have listened to what Deputy Kenny said and it is false. The screening programme provides the greater certainty where 95% of all cancers can be identified. The vaccination...
- Leaders' Questions (12 Nov 2008)
Brian Cowen: The issue is how we ensure people are protected from getting cervical cancer. Providing a national screening programme is the first step in that effort. We are providing an extra â¬25 million next year to ensure that happens. We are providing another â¬15 million to ensure Professor Tom Keane has the proper treatment regimes in place in the centres of excellence he has been establishing....
- Order of Business (12 Nov 2008)
Brian Cowen: ...(Miscellaneous Provisions) Bill 2008 â Second Stage (resumed) shall, if not previously concluded, be brought to a conclusion at 10 p.m. Private Members' Business shall be No. 40, motion re cervical cancer (resumed) to conclude at 8.30 p.m., if not previously concluded.
- Order of Business (11 Nov 2008)
Brian Cowen: ...anything in Standing Orders, that the Dáil shall sit later than 8.30 p.m. and business shall be interrupted not later than 10 p.m. Private Members' business shall be No. 40, motion re cervical cancer vaccination programme.
- Leaders' Questions (5 Nov 2008)
Brian Cowen: ...and expansion of the cancer control programme under Professor Tom Keane remains a priority and funding of â¬15 million has been made available for this purpose. At present, the national cervical screening programme, CervicalCheck, is being rolled out with a full-year cost of â¬35 million. The programme will provide free smear tests through primary care settings to the 1.1 million women...